Global Transcatheter Aortic Valve Replacement (TAVR) Market: Industry Analysis & Outlook (2017-2021)
Transcatheter aortic valve replacement (TAVR) is a relatively new technology in the field of medical science. It is a less intrusive method of replacing heart valve without undergoing the conventional by-pass surgery. Due to the less invasive nature of the surgery, it has emerged as the more feasible alternative to conventional surgical aortic valve replacement. Transcatheter aortic valve replacement is sometimes called as Transcatheter aortic valve implantation (TAVI). TAVR may be an option for people who are considered at intermediate or high risk of complications from surgical aortic valve replacement. It may also be suggested in certain cases where patient cannot undergo open-heart surgery. The decision to treat aortic stenosis with TAVR is made after consultation with a multidisciplinary group of medical and surgical heart specialists who together determine the best treatment option for each individual.
The global TAVR market is set to experience favourable growth driven by factors such as increasing elderly population, rising health care expenditure, increasing obese population and global economic development. Further, the scope of growth for this market will be broadened by increasing prevalence of aortic stenosis amongst the patients and rising demand for minimally invasive procedures. However, the growth of this budding market will be hindered by the business cycle fluctuations and risk of security breaches such as stringent regulations, high cost of TAVR devices and high risks associated with the TAVR procedure.
The report “Global TAVR Market: Industry Analysis & Outlook (2017-2021)” analyses the development of this market, with focus on the U.S, Asia Pacific and European markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Edwards Lifesciences, Boston Scientific, Medtronic Plc. and St. Jude Medical, Inc. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global TAVR market along with the study of the regional markets.
The global TAVR market is set to experience favourable growth driven by factors such as increasing elderly population, rising health care expenditure, increasing obese population and global economic development. Further, the scope of growth for this market will be broadened by increasing prevalence of aortic stenosis amongst the patients and rising demand for minimally invasive procedures. However, the growth of this budding market will be hindered by the business cycle fluctuations and risk of security breaches such as stringent regulations, high cost of TAVR devices and high risks associated with the TAVR procedure.
The report “Global TAVR Market: Industry Analysis & Outlook (2017-2021)” analyses the development of this market, with focus on the U.S, Asia Pacific and European markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Edwards Lifesciences, Boston Scientific, Medtronic Plc. and St. Jude Medical, Inc. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global TAVR market along with the study of the regional markets.
1. INTRODUCTION
1.1 TAVR Overview
2. GLOBAL MARKET ANALYSIS
2.1 Global TAVR Market by Value
2.2 Global TAVR Market Forecast by Value
2.3 Global TAVR Implant Volume
2.4 Global TAVR Implant Volume Forecast
2.5 Global TAVR Patient Population
2.6 Global TAVR Patient Population Forecast
3. REGIONAL MARKET ANALYSIS
3.1 The U.S.
3.1.1 The U.S. TAVR Market by Value
3.1.2 The U.S TAVR Forecast by Value
3.1.3 The U.S. TAVR Implant Volume
3.1.4 The U.S. TAVR Implant Volume Forecast
3.1.5 The U.S. TAVR Implant Volume by Patient Type
3.1.6 The U.S. TAVR Implant Volume Forecast-Patient Type
3.1.7 The U.S. TAVR Implant Volume by Access Route
3.1.8 The U.S. Aortic Valve Disease Patient Population Forecast
3.2 Outside the U.S.
3.2.1 OUS TAVR Market by Value
3.2.2 OUS TAVR Market Forecast by Value
3.2.3 OUS TAVR Implant Volume
3.2.4 OUS TAVR Implant Forecast by Volume
3.2.5 OUS TAVR Patient Population
3.2.6 OUS TAVR Patient Population Forecast
3.2.7 Europe TAVR Implant Volume by Patient Type
3.2.8 Europe TAVR Implant Volume Forecast by Patient Type
3.2.9 Europe TAVR Implant Volume by Access Route
4. MARKET DYNAMICS
4.1 Growth Drivers
4.1.1 Rising Aging Population
4.1.2 Rising HealthCare Expenditure
4.1.3 Increasing Obese Population
4.1.4 Economic Development
4.1.5 Increasing Prevalence of Inoperable Aortic Stenosis
4.2 Key Trends & Development
4.2.1 Recent Technological Advancements
4.2.2 Favourable Reimbursement Policies in Europe
4.3 Challenges
4.3.1 Stringent Regulations
4.3.2 High Cost of TAVR Devices
4.3.3 Associated High Risk
5. COMPETITION
5.1 Global Market
5.1.1 Global TAVR Market Share by Company
5.1.2 Global TAVR Market-Implanting Centres by Company
5.1.3 Global TAVR Market-Total Implants by Company
5.1.4 Global TAVR Market-Average Selling Price of Implants by Company
5.2 The U.S.
5.2.1 The U.S. TAVR Market Share by Company
5.2.2 The U.S. TAVR Market-Implanting Centres by Company
5.2.3 The U.S. TAVR Market-Total Implants by Company
5.2.4 The U.S. TAVR Market-Average Selling Price of Implants by Company
5.3 Outside the U.S.
5.3.1 OUS TAVR Market Share by Company
5.3.2 OUS TAVR Market- Implanting Centres by Company
5.3.3 OUS TAVR Market- Total Implants by Company
5.3.4 OUS TAVR Market-Average Selling Price of Implants by Company
6. COMPANY PROFILES
6.1 Edwards Lifesciences
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Boston Scientific
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Medtronic Plc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 St. Jude Medical, Inc.
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
1.1 TAVR Overview
2. GLOBAL MARKET ANALYSIS
2.1 Global TAVR Market by Value
2.2 Global TAVR Market Forecast by Value
2.3 Global TAVR Implant Volume
2.4 Global TAVR Implant Volume Forecast
2.5 Global TAVR Patient Population
2.6 Global TAVR Patient Population Forecast
3. REGIONAL MARKET ANALYSIS
3.1 The U.S.
3.1.1 The U.S. TAVR Market by Value
3.1.2 The U.S TAVR Forecast by Value
3.1.3 The U.S. TAVR Implant Volume
3.1.4 The U.S. TAVR Implant Volume Forecast
3.1.5 The U.S. TAVR Implant Volume by Patient Type
3.1.6 The U.S. TAVR Implant Volume Forecast-Patient Type
3.1.7 The U.S. TAVR Implant Volume by Access Route
3.1.8 The U.S. Aortic Valve Disease Patient Population Forecast
3.2 Outside the U.S.
3.2.1 OUS TAVR Market by Value
3.2.2 OUS TAVR Market Forecast by Value
3.2.3 OUS TAVR Implant Volume
3.2.4 OUS TAVR Implant Forecast by Volume
3.2.5 OUS TAVR Patient Population
3.2.6 OUS TAVR Patient Population Forecast
3.2.7 Europe TAVR Implant Volume by Patient Type
3.2.8 Europe TAVR Implant Volume Forecast by Patient Type
3.2.9 Europe TAVR Implant Volume by Access Route
4. MARKET DYNAMICS
4.1 Growth Drivers
4.1.1 Rising Aging Population
4.1.2 Rising HealthCare Expenditure
4.1.3 Increasing Obese Population
4.1.4 Economic Development
4.1.5 Increasing Prevalence of Inoperable Aortic Stenosis
4.2 Key Trends & Development
4.2.1 Recent Technological Advancements
4.2.2 Favourable Reimbursement Policies in Europe
4.3 Challenges
4.3.1 Stringent Regulations
4.3.2 High Cost of TAVR Devices
4.3.3 Associated High Risk
5. COMPETITION
5.1 Global Market
5.1.1 Global TAVR Market Share by Company
5.1.2 Global TAVR Market-Implanting Centres by Company
5.1.3 Global TAVR Market-Total Implants by Company
5.1.4 Global TAVR Market-Average Selling Price of Implants by Company
5.2 The U.S.
5.2.1 The U.S. TAVR Market Share by Company
5.2.2 The U.S. TAVR Market-Implanting Centres by Company
5.2.3 The U.S. TAVR Market-Total Implants by Company
5.2.4 The U.S. TAVR Market-Average Selling Price of Implants by Company
5.3 Outside the U.S.
5.3.1 OUS TAVR Market Share by Company
5.3.2 OUS TAVR Market- Implanting Centres by Company
5.3.3 OUS TAVR Market- Total Implants by Company
5.3.4 OUS TAVR Market-Average Selling Price of Implants by Company
6. COMPANY PROFILES
6.1 Edwards Lifesciences
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Boston Scientific
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Medtronic Plc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 St. Jude Medical, Inc.
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
LIST OF CHARTS
Approaches to TAVR Procedure
Global TAVR Market by Value (2012-2016)
Global TAVR Market Forecast by Value (2017-2021)
Global TAVR Implant Volume (2012-2016)
Global TAVR Implant Volume Forecast (2017-2021)
Global TAVR Patient Population (2012-2016)
Global TAVR Patient Population Forecast (2017-2021)
The U.S. TAVR Market by Value (2012-2016)
The U.S. TAVR Market Forecast by Value (2017-2021)
The U.S. TAVR Implant Volume (2012-2016)
The U.S. TAVR Implant Volume Forecast (2017-2021)
The U.S. TAVR Implant Volume- Patient Type (2016)
The U.S. TAVR Implant Volume Forecast- Patient Type (2017-2021)
The U.S. TAVR Implant Volume- Access Route (2016)
The U.S. Aortic Valve Disease Patient Population Forecast (2016-2021)
OUS TAVR Market by Value (2012-2016)
OUS TAVR Market Forecast by Value (2017-2021)
OUS TAVR Implant Volume (2012-2016)
OUS TAVR Implant Forecast by Volume (2017-2021)
OUS TAVR Patient Population (2012-2016)
OUS TAVR Patient Population Forecast (2017-2021)
Europe TAVR Implant Volume by Patient Type (2016)
Europe TAVR Implant Volume Forecast -Patient Type (2017-2021)
Europe TAVR Implant Volume- Access Route (2016)
Global Population Above 65 Years (2012-2016)
Global HealthCare Expenditure Per Capita (2012-2016)
Global Obese Population (2012-2016)
Global GDP Per Capita (2012-2016)
Global TAVR Market Share by Company (2016/2021)
Global TAVR Market- Implanting Centres by Company (2016-2021)
Global TAVR Market- Total Implants by Company (2016-2021)
Global TAVR Market- Average Selling Price of Implants by Company (2016-2021)
The U.S. TAVR Market Share by Company (2016/2021)
The U.S. TAVR Market-Implanting Centres by Company (2016-2021)
The U.S. TAVR Market-Total Implants by Company (2016-2021)
The U.S. TAVR Market-Average Selling Price of Implants by Company (2016-2021)
OUS TAVR Market Share by Company (2016/2021)
OUS TAVR Market-Implanting Centres by Company (2016-2021)
OUS TAVR Market-Total Implants by Company (2016-2021)
OUS TAVR Market-Average Selling Price of Implants by Company (2016-2021)
Edwards Lifesciences Revenue by Segments (2016)
Edwards Lifesciences Revenue and Net Income (2012-2016)
Boston Scientific Net Sales by Segments (2016)
Boston Scientific Net Sales and Net Income (2012-2016)
Medtronic Plc. Net Sales by Segments (2016)
Medtronic Plc. Net Sales and Net Income (2012-2016)
St. Jude Medical, Inc. Revenue by Segments (2015)
St. Jude Medical, Inc. Net Sales and Net Earnings (2011-2015)
Approaches to TAVR Procedure
Global TAVR Market by Value (2012-2016)
Global TAVR Market Forecast by Value (2017-2021)
Global TAVR Implant Volume (2012-2016)
Global TAVR Implant Volume Forecast (2017-2021)
Global TAVR Patient Population (2012-2016)
Global TAVR Patient Population Forecast (2017-2021)
The U.S. TAVR Market by Value (2012-2016)
The U.S. TAVR Market Forecast by Value (2017-2021)
The U.S. TAVR Implant Volume (2012-2016)
The U.S. TAVR Implant Volume Forecast (2017-2021)
The U.S. TAVR Implant Volume- Patient Type (2016)
The U.S. TAVR Implant Volume Forecast- Patient Type (2017-2021)
The U.S. TAVR Implant Volume- Access Route (2016)
The U.S. Aortic Valve Disease Patient Population Forecast (2016-2021)
OUS TAVR Market by Value (2012-2016)
OUS TAVR Market Forecast by Value (2017-2021)
OUS TAVR Implant Volume (2012-2016)
OUS TAVR Implant Forecast by Volume (2017-2021)
OUS TAVR Patient Population (2012-2016)
OUS TAVR Patient Population Forecast (2017-2021)
Europe TAVR Implant Volume by Patient Type (2016)
Europe TAVR Implant Volume Forecast -Patient Type (2017-2021)
Europe TAVR Implant Volume- Access Route (2016)
Global Population Above 65 Years (2012-2016)
Global HealthCare Expenditure Per Capita (2012-2016)
Global Obese Population (2012-2016)
Global GDP Per Capita (2012-2016)
Global TAVR Market Share by Company (2016/2021)
Global TAVR Market- Implanting Centres by Company (2016-2021)
Global TAVR Market- Total Implants by Company (2016-2021)
Global TAVR Market- Average Selling Price of Implants by Company (2016-2021)
The U.S. TAVR Market Share by Company (2016/2021)
The U.S. TAVR Market-Implanting Centres by Company (2016-2021)
The U.S. TAVR Market-Total Implants by Company (2016-2021)
The U.S. TAVR Market-Average Selling Price of Implants by Company (2016-2021)
OUS TAVR Market Share by Company (2016/2021)
OUS TAVR Market-Implanting Centres by Company (2016-2021)
OUS TAVR Market-Total Implants by Company (2016-2021)
OUS TAVR Market-Average Selling Price of Implants by Company (2016-2021)
Edwards Lifesciences Revenue by Segments (2016)
Edwards Lifesciences Revenue and Net Income (2012-2016)
Boston Scientific Net Sales by Segments (2016)
Boston Scientific Net Sales and Net Income (2012-2016)
Medtronic Plc. Net Sales by Segments (2016)
Medtronic Plc. Net Sales and Net Income (2012-2016)
St. Jude Medical, Inc. Revenue by Segments (2015)
St. Jude Medical, Inc. Net Sales and Net Earnings (2011-2015)
